Promise of Real-World Evidence for Patient Centricity in Gulf Cooperation Council Countries: Call to Action
- PMID: 36394823
- PMCID: PMC9944129
- DOI: 10.1007/s40801-022-00336-0
Promise of Real-World Evidence for Patient Centricity in Gulf Cooperation Council Countries: Call to Action
Abstract
Presently, Gulf Cooperation Council countries are lagging in the generation of real-world data and use of real-world evidence for patient-centered care compared with the global average. In a collaborative effort, experts from multiple domains of the healthcare environment from the Gulf Cooperation Council countries came together to present their views and recommended key action points for the generation of robust real-world data and leveraging real-world evidence in the countries. The opinions of the experts are presented, along with existing barriers to the effective generation of real-world evidence in the countries. The Gulf Cooperation Council countries are undergoing transformative changes paving the way for improved healthcare measures; however, the challenges in generating reliable, robust, accessible, and secure real-world evidence are persistent. Hence, ongoing public-private engagements, as well as collaborations between regulators, policymakers, healthcare professionals, insurance and pharmaceutical companies, and patients, are warranted. A few notable examples of real-world evidence studies highlighting the benefits of real-world evidence for gaining valuable insights into patient-centric decision making are also discussed. The actionable steps identified for successful real-world evidence generation would provide long-term, real-world evidence-based patient-centric benefits for the countries.
© 2022. The Author(s).
Conflict of interest statement
MF, IG, WM, AA, SA, TS, NA, SG, MI, HM, MC, YA,MB, AG, KM, and NSA have no conflicts of interest that are directly relevant to the content of this article.
Similar articles
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Real-world effectiveness and safety profile of teriflunomide in the management of multiple sclerosis in the Gulf Cooperation Council countries: An expert consensus narrative review.Mult Scler J Exp Transl Clin. 2022 Mar 9;8(1):20552173221077185. doi: 10.1177/20552173221077185. eCollection 2022 Jan-Mar. Mult Scler J Exp Transl Clin. 2022. PMID: 35284088 Free PMC article.
-
Unlocking the eHealth professionals' career pathways: A case of Gulf Cooperation Council countries.Int J Med Inform. 2023 Feb;170:104914. doi: 10.1016/j.ijmedinf.2022.104914. Epub 2022 Nov 11. Int J Med Inform. 2023. PMID: 36521421
-
Driving and diabetes mellitus in the Gulf Cooperation Council countries: Call for action.Diabetes Res Clin Pract. 2015 Oct;110(1):91-94. doi: 10.1016/j.diabres.2015.08.002. Epub 2015 Aug 22. Diabetes Res Clin Pract. 2015. PMID: 26345248 Review.
-
Association of infections with multiple sclerosis in Gulf Cooperation Council countries: a review.J Int Med Res. 2020 Apr;48(4):300060519884151. doi: 10.1177/0300060519884151. Epub 2019 Dec 27. J Int Med Res. 2020. PMID: 31880177 Free PMC article. Review.
Cited by
-
Patterns of claims and determinants of claim rejections in Kuwait's National Health Insurance for Retirees (AFYA): a comprehensive analysis.Front Public Health. 2025 Jul 22;13:1606980. doi: 10.3389/fpubh.2025.1606980. eCollection 2025. Front Public Health. 2025. PMID: 40766021 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Miscellaneous